Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al
Conclusion In this review, we have provided an extensive overview of the main questions that remain unanswered regarding the molecular pathogenesis of SCA3, and what does the extensive and high-quality research so far teach us on the more likely initial events that compromise cellular function
Compounded multi-agent topicalscombining a DHT blocker, a vasodilator, an anti-inflammatory, and an antifungal in one applicationcan address several pathways simultaneously, improving adherence by reducing the number of products a patient has to apply
GHK-Cu has demonstrated activity on keratinocyte growth factor (KGF) and hepatocyte growth factor (HGF) pathways, both of which support intestinal epithelial renewal